Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. 

Biotechnology

Sorrento Therapeutics

Henry Ji

David S.

Wenying Zhang

Ting-Fang Zheng

Tanya Chen

Sungwoong Kim

Soonpin Yei

Siyi Xi

Silpa Yalamanchili

Krystal Lin

Linh Tran

Lingmin Yuan

Lan Tang

Junlai Liu

Jiawei Wang

Bill Raab

Araceli Alvarez

Ana Ruiza Loren David

Yu Huang

Qiao Jin

Kyle Brown

Yulia Kushnareva

Yongxin Mu

Yanqi Y.

Yan Li

Xiao He

Ming Zhao

Mariyam Zuberi

Jianbo Wu

Jehan Yousif Azeez

Ivo Rimann

Irina Krapf

Gregory T Mrachko Ph.D., Rac

Geanie Pai

Lin Lin

Tong Zhu

Haihong Jiang

Jeffrey Su

Aline Sullivan-Thoeny

Scott Schaus

Wenzhong Guo

Xiao Xu

Shawn Sahebi

Mark R. Brunswick

Research and Development Team

Leadership Team

Finance and Regulatory Team

Technical Operations Team

Teams at Sorrento Therapeutics

Research and Development Team

Leadership Team

Finance and Regulatory Team

Technical Operations Team